ArticleJournal of breast cancer2014

Efficacy and Safety Profile of Combining Sorafenib with Chemotherapy in Patients with HER2-Negative Advanced Breast Cancer: A Meta-analysis.

Jie Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.